- Home
- CANF vs SOAR Comparison
CANF vs SOAR Comparison
Compare CANF & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CANF | SOAR |
|---|---|---|
| Founded | 1994 | 2021 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 5.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CANF | SOAR |
|---|---|---|
| Price | $4.11 | $0.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9,750.00 | N/A |
| AVG Volume (30 Days) | 74.6K | ★ 5.2M |
| Earning Date | 03-26-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.32 |
| Revenue | $560,000.00 | ★ $58,312,000.00 |
| Revenue This Year | $461.72 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.36 | $0.41 |
| 52 Week High | $46.60 | $6.48 |
Technical Indicators
Market Signals| Indicator | CANF | SOAR |
|---|---|---|
| Relative Strength Index (RSI) | 64.56 | 36.00 |
| Support Level | $4.00 | $0.57 |
| Resistance Level | $4.32 | $0.94 |
| Average True Range (ATR) | 0.29 | 0.12 |
| MACD | -0.16 | 0.03 |
| Stochastic Oscillator | 31.61 | 11.55 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.